Press releaseBusiness Wire
bioAffinity Technologies
BIAF · NASDAQ
$3.66+$0.19 (+5.48%)TodayMarket closed ·
Prev close $3.47
Latest news
- Press releaseBusiness Wire
bioAffinity Technologies to Present Positive Research Data in Development of Its New Test Measuring Asthma and COPD-Related Lung Inflammation and Drug-Related Receptors at CHEST 2026
- Press releasePRNewswire
WallachBeth Capital Announces Closing of bioAffinity Technologies $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
- Press releaseBusiness Wire
bioAffinity Technologies, Inc. Announces Closing of $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
- Press releasePRNewswire
WallachBeth Capital Announces bioAffinity Technologies Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
- Press releaseBusiness Wire
bioAffinity Technologies, Inc. Announces Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
- Press releaseBusiness Wire
bioAffinity Technologies Announces Notification of Japanese Patent Allowance Covering Noninvasive CyPath® Lung and AI-Built Algorithm
- Press releaseBusiness Wire
bioAffinity Technologies Reports Over 100% Growth in CyPath® Lung Sales Through Third Quarter 2026
- Press releaseBusiness Wire
bioAffinity Technologies Promotes Veteran Awareness and Access to Its Noninvasive CyPath® Lung Cancer Test Through Distribution Partnership with Veteran-Owned AvMEDICAL
- Press releaseBusiness Wire
bioAffinity Technologies to Present Positive Clinical and Veteran-Focused Data on CyPath® Lung at NAVREF 2026 Annual Conference
- NewsHenry Khederian
BioAffinity Technologies Stock Surges Following Hong Kong Patent Grant
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- Press releaseGlobe Newswire
Four High-Impact Small Caps Enter the Spotlight
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Press releaseBusiness Wire
bioAffinity Technologies Announces Grant of Hong Kong Patent for Company's CyPath® Lung Noninvasive Lung Cancer Diagnostic
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- Press releaseGlobe Newswire
Four Biotech Stories Heating Up Right Now
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- Press releaseBusiness Wire
bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements
- NewsAvi Kapoor
Dow Tumbles 450 Points; US Small Business Sentiment Declines In August
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- Press releaseBusiness Wire
bioAffinity Technologies to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- NewsHenry Khederian
BioAffinity Technologies Stock Skyrockets Wednesday: What's Happening?
- NewsAvi Kapoor
Dow Surges Over 200 Points; Ollie's Bargain Outlet Shares Gain After Q2 Earnings
- NewsVandana Singh
BioAffinity Advances Noninvasive CyPath Lung Test For Post-Treatment Monitoring
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- NewsAvi Kapoor
Crude Oil Surges 3%; ISM Manufacturing PMI Falls In August
- NewsAvi Kapoor
Dow Dips Over 300 Points; Medtronic Shares Gain After Upbeat Q1 Earnings
- Press releaseBusiness Wire
bioAffinity Technologies Advances CyPath® Lung for Surveillance of Lung Cancer Survivors
- Press releaseBusiness Wire
bioAffinity Technologies Announces 1-for-15 Reverse Stock Split Effective at the Open of Trading on August 24, 2026
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Press releaseBusiness Wire
bioAffinity Technologies and AvMEDICAL Announce Nationwide Federal Healthcare Distribution Agreement for CyPath® Lung
- Press releaseBusiness Wire
bioAffinity Technologies Reports Second Quarter 2026 Results and Continued Strong Commercial Momentum for CyPath® Lung
- Press releaseBusiness Wire
bioAffinity Technologies and Pictor®, Inc. Partner to Develop and Commercialize bioAffinity’s Diagnostics for Asthma and COPD
- Press releaseBusiness Wire
bioAffinity Technologies’ Quarterly CyPath® Lung Sales Double to New Record as Commercial Momentum Continues
- NewsAvi Kapoor
Crude Oil Gains Around 2%; Elbit Systems Shares Jump On Upbeat Earnings
- NewsAvi Kapoor
Nasdaq Surges Over 100 Points; Academy Sports And Outdoors Posts Downbeat Earnings
- NewsAvi Kapoor
Crude Oil Gains Over 1%; VEON Shares Spike Higher
- NewsAvi Kapoor
Dow Gains Over 300 Points; US GDP Growth Revised Lower In Q4
- NewsAvi Kapoor
Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
- NewsAvi Kapoor
Nasdaq Gains 100 Points; US Consumer Sentiment Falls
- NewsAvi Kapoor
Dow Jumps Over 250 Points; Fed's Key Inflation Gauge Remains Hot
- NewsAvi Kapoor
Why Bullish Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
- NewsAvi Kapoor
Why Webtoon Entertainment Shares Are Trading Higher By 48%; Here Are 20 Stocks Moving Premarket
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.